Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Losartan carboxylic acid is an antagonist of the angiotensin II type 1b (AT1b) receptor (Ki = 0.67 nM in COS-7 cells expressing the human receptor) and an active metabolite of losartan (Item No. 10006594).1,2 It is formed from losartan by the cytochrome P450 (CYP) isoform CYP2C9. Losartan carboxylic acid is selective for AT1b over AT2 (Ki = >10,000 nM in COS-7 cells expressing the human receptor). It reduces U-44619-induced aggregation of platelets in isolated human platelet-rich plasma when used at a concentration of 50 µM.3 Losartan carboxylic acid (1 mg/kg) reduces mean arterial pressure (MAP) in water-deprived rats.4
WARNING This product is not for human or veterinary use.
1. Binding of KRH-
2. Role of CYP2C9 polymorphism in losartan oxidation. Drug Metab. Dispos. 29(7), 1051-1056 (2001).
3. Use of angiotensin receptor blockers in cardiovascular protection: Current evidence and future directions. PT 36(1), 22-40 (2011).
4. Comparison of the regional haemodynamic effects of the AT1-